Atıf Formatları
Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

G. Ayvaz Et Al. , "Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study," Current Medical Research and Opinion , vol.31, no.4, pp.623-632, 2015

Ayvaz, G. Et Al. 2015. Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study. Current Medical Research and Opinion , vol.31, no.4 , 623-632.

Ayvaz, G., Keskin, L., Akin, T. F., Dokmetas, H. S., Tasan, E., Ar, I. B., ... Uren, E.(2015). Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study. Current Medical Research and Opinion , vol.31, no.4, 623-632.

Ayvaz, Goksun Et Al. "Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study," Current Medical Research and Opinion , vol.31, no.4, 623-632, 2015

Ayvaz, Goksun Et Al. "Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study." Current Medical Research and Opinion , vol.31, no.4, pp.623-632, 2015

Ayvaz, G. Et Al. (2015) . "Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study." Current Medical Research and Opinion , vol.31, no.4, pp.623-632.

@article{article, author={Goksun Ayvaz Et Al. }, title={Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study}, journal={Current Medical Research and Opinion}, year=2015, pages={623-632} }